Metastasis is a complex and violent process involving multiple steps and a multitude of assaults. It is intricate, and one of biology's biggest intrigue. Unfortunately, it is also one of the biggest killers. With the advent of chemotherapy, patients with localized diseases have seen a tremendous improvement in their survival rates. This is true for most cancers, including Ewing sarcoma. On the other hand, particularly for Ewing sarcoma, little to no improvement has been made for patients with metastatic or recurrent disease. The survival rate for these patients has been stuck at a devastating 25-30% for last several decades.
Our lab uses a multi-omics approach, cutting edge spatial analysis, and innovative in vivo and ex vivo model systems as tools to investigate the molecular mechanisms that drive progression and lung metastasis in Ewing sarcoma. Patient-derived tumors and metastatic cell lines developed in the lab allow us to unravel this complex process with the ultimate aim of identifying novel therapeutic targets.
Read more on our ongoing projects here.